593 related articles for article (PubMed ID: 31505040)
21. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.
Wang X; Zheng Z; Caviglia JM; Corey KE; Herfel TM; Cai B; Masia R; Chung RT; Lefkowitch JH; Schwabe RF; Tabas I
Cell Metab; 2016 Dec; 24(6):848-862. PubMed ID: 28068223
[TBL] [Abstract][Full Text] [Related]
22. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
23. YAP and TAZ are distinct effectors of corneal myofibroblast transformation.
Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ
Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787
[TBL] [Abstract][Full Text] [Related]
24. YAP and TAZ protect against white adipocyte cell death during obesity.
Wang L; Wang S; Shi Y; Li R; Günther S; Ong YT; Potente M; Yuan Z; Liu E; Offermanns S
Nat Commun; 2020 Oct; 11(1):5455. PubMed ID: 33116140
[TBL] [Abstract][Full Text] [Related]
25. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis.
Zhu C; Tabas I; Schwabe RF; Pajvani UB
Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):131-142. PubMed ID: 33051603
[TBL] [Abstract][Full Text] [Related]
26. Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation.
Garoffolo G; Casaburo M; Amadeo F; Salvi M; Bernava G; Piacentini L; Chimenti I; Zaccagnini G; Milcovich G; Zuccolo E; Agrifoglio M; Ragazzini S; Baasansuren O; Cozzolino C; Chiesa M; Ferrari S; Carbonaro D; Santoro R; Manzoni M; Casalis L; Raucci A; Molinari F; Menicanti L; Pagano F; Ohashi T; Martelli F; Massai D; Colombo GI; Messina E; Morbiducci U; Pesce M
Circ Res; 2022 Jul; 131(3):239-257. PubMed ID: 35770662
[TBL] [Abstract][Full Text] [Related]
27. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK
Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780
[TBL] [Abstract][Full Text] [Related]
28. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q
Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.
Hyun J; Al Abo M; Dutta RK; Oh SH; Xiang K; Zhou X; Maeso-Díaz R; Caffrey R; Sanyal AJ; Freedman JA; Patierno SR; Moylan CA; Abdelmalek MF; Diehl AM
J Hepatol; 2021 Sep; 75(3):623-633. PubMed ID: 33964370
[TBL] [Abstract][Full Text] [Related]
30. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
31. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
33. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte-specific TAZ deletion downregulates p62/ Sqstm1 expression in nonalcoholic steatohepatitis.
Yang X; Sheng S; Du X; Su W; Tian J; Zhao X
Biochem Biophys Res Commun; 2021 Jan; 535():60-65. PubMed ID: 33341674
[TBL] [Abstract][Full Text] [Related]
35. Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.
Costa CRR; Chalgoumi R; Baker A; Guillou C; Yamaguti PM; Simancas Escorcia V; Abbad L; Amorin BR; de Lima CL; Cannaya V; Benassarou M; Berdal A; Chatziantoniou C; Cases O; Cosette P; Kozyraki R; Acevedo AC
Sci Rep; 2024 Apr; 14(1):9497. PubMed ID: 38664418
[TBL] [Abstract][Full Text] [Related]
36. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
37. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
[TBL] [Abstract][Full Text] [Related]
38. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38813860
[TBL] [Abstract][Full Text] [Related]
39. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
